Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of August 13, 2026, CRBU trades at $1.65 with a market cap of $168.61M and a P/E ratio of -1.15. CRBU moved -5.88% today. Year to date, CRBU is +1.26%; over the trailing twelve months it is -17.44%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $8.33. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
3 analysts cover CRBU: 0 strong buy, 3 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.33.
| Metric | Value |
|---|---|
| Price | $1.65 |
| Market Cap | $168.61M |
| P/E Ratio | -1.15 |
| EPS | $-1.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.66 |
| Volume | 1.03M |
| Avg Volume | 0 |
| Revenue (TTM) | $11.20M |
| Net Income | $-133.22M |
| Gross Margin | 0.00% |
3 analysts cover CRBU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.33.